Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 the Board approved the appointment of Mr. Rajendra Prasad (DIN: 10871533) as an Additional & Non-Executive Director of the Company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Johnson Pharmacare Ltd, at its meeting held on 24 January 2026, approved the appointment of Mr. Rajender Parsad (DIN: 10871533) as an Additional & Non-Executive Director with effect from 24 January 2026. Mr. Parsad, born on 1 October 1969, is a graduate and has confirmed that he is not debarred from holding the office of director by any authority including SEBI or any court. The disclosure was filed with BSE under Regulation 30 of SEBI LODR Regulations, 2015. The letter is signed by Umesh Kumar, Additional Director of the company.
This is a routine board-level addition with no disclosed operational or financial implications. Shareholders should note the change in board composition, but the appointment of a non-executive director typically does not materially affect the stock price or business direction.